Aoife Kilcoyne, Mb.Bch,Bao
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometriosis | 5 | 2023 | 839 | 1.160 |
Why?
|
| Granulosa Cell Tumor | 1 | 2023 | 71 | 0.850 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2023 | 105 | 0.800 |
Why?
|
| Vulvar Neoplasms | 2 | 2021 | 272 | 0.730 |
Why?
|
| Fallopian Tube Diseases | 1 | 2020 | 62 | 0.720 |
Why?
|
| Diverticulitis | 1 | 2022 | 171 | 0.700 |
Why?
|
| Infertility, Female | 3 | 2020 | 787 | 0.660 |
Why?
|
| Molecular Imaging | 2 | 2016 | 831 | 0.660 |
Why?
|
| Appendicitis | 2 | 2022 | 645 | 0.630 |
Why?
|
| Lymph Nodes | 6 | 2020 | 3469 | 0.600 |
Why?
|
| Ovarian Neoplasms | 3 | 2023 | 4837 | 0.590 |
Why?
|
| Patient Positioning | 2 | 2016 | 323 | 0.580 |
Why?
|
| Fluorodeoxyglucose F18 | 7 | 2022 | 2017 | 0.570 |
Why?
|
| Endometrial Neoplasms | 3 | 2021 | 1353 | 0.550 |
Why?
|
| Femoral Nerve | 1 | 2016 | 39 | 0.550 |
Why?
|
| Radiology | 5 | 2022 | 2099 | 0.530 |
Why?
|
| Radiography, Interventional | 3 | 2018 | 1095 | 0.510 |
Why?
|
| Urologic Diseases | 1 | 2016 | 244 | 0.460 |
Why?
|
| Ureter | 1 | 2016 | 374 | 0.460 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2016 | 324 | 0.450 |
Why?
|
| Placenta Accreta | 1 | 2016 | 225 | 0.440 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2023 | 35423 | 0.440 |
Why?
|
| Crohn Disease | 4 | 2019 | 2303 | 0.400 |
Why?
|
| Cryosurgery | 1 | 2016 | 452 | 0.390 |
Why?
|
| Laparoscopy | 1 | 2023 | 2149 | 0.390 |
Why?
|
| Diagnostic Imaging | 6 | 2021 | 3508 | 0.370 |
Why?
|
| Urinary Bladder | 1 | 2016 | 1172 | 0.350 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 1255 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2022 | 20123 | 0.310 |
Why?
|
| Positron-Emission Tomography | 4 | 2022 | 6274 | 0.310 |
Why?
|
| Prostatic Neoplasms | 4 | 2020 | 11074 | 0.300 |
Why?
|
| Femoral Fractures | 1 | 2011 | 376 | 0.300 |
Why?
|
| Intestines | 1 | 2016 | 1924 | 0.280 |
Why?
|
| Diphosphonates | 1 | 2011 | 624 | 0.280 |
Why?
|
| Image Enhancement | 1 | 2016 | 2921 | 0.260 |
Why?
|
| Uterus | 3 | 2020 | 710 | 0.260 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2727 | 0.250 |
Why?
|
| Nanoparticles | 1 | 2016 | 1905 | 0.250 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 2636 | 0.250 |
Why?
|
| Genital Neoplasms, Female | 2 | 2023 | 522 | 0.250 |
Why?
|
| Radiopharmaceuticals | 7 | 2022 | 2662 | 0.250 |
Why?
|
| Diagnosis, Differential | 13 | 2019 | 12961 | 0.240 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 2 | 2016 | 182 | 0.240 |
Why?
|
| Ablation Techniques | 2 | 2018 | 249 | 0.240 |
Why?
|
| Carcinoma | 1 | 2016 | 2375 | 0.240 |
Why?
|
| Bone Density Conservation Agents | 1 | 2011 | 773 | 0.240 |
Why?
|
| Contrast Media | 7 | 2019 | 5300 | 0.230 |
Why?
|
| Kidney | 2 | 2016 | 7183 | 0.230 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 1912 | 0.230 |
Why?
|
| Hysterosalpingography | 2 | 2020 | 30 | 0.230 |
Why?
|
| Pelvis | 3 | 2023 | 729 | 0.220 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2022 | 133 | 0.210 |
Why?
|
| Humans | 60 | 2023 | 744220 | 0.200 |
Why?
|
| Female | 40 | 2023 | 380197 | 0.190 |
Why?
|
| Vaginal Neoplasms | 1 | 2021 | 106 | 0.190 |
Why?
|
| Gastrointestinal Diseases | 2 | 2020 | 1169 | 0.190 |
Why?
|
| Menstrual Hygiene Products | 1 | 2020 | 18 | 0.190 |
Why?
|
| Lymphatic Metastasis | 3 | 2020 | 2914 | 0.190 |
Why?
|
| Peer Review | 1 | 2022 | 209 | 0.180 |
Why?
|
| Radiography | 4 | 2022 | 7022 | 0.180 |
Why?
|
| Sensitivity and Specificity | 7 | 2022 | 14726 | 0.170 |
Why?
|
| Abdomen | 3 | 2022 | 1118 | 0.170 |
Why?
|
| Jaundice | 1 | 2019 | 89 | 0.170 |
Why?
|
| Faculty | 1 | 2022 | 386 | 0.170 |
Why?
|
| Digestive System Diseases | 1 | 2020 | 147 | 0.170 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2018 | 31 | 0.170 |
Why?
|
| Menstruation | 1 | 2020 | 300 | 0.160 |
Why?
|
| Uterine Hemorrhage | 1 | 2020 | 255 | 0.160 |
Why?
|
| Predictive Value of Tests | 5 | 2019 | 15070 | 0.160 |
Why?
|
| Neoplasms | 5 | 2020 | 21672 | 0.160 |
Why?
|
| Pelvic Neoplasms | 1 | 2020 | 254 | 0.160 |
Why?
|
| Liver Neoplasms | 3 | 2020 | 4252 | 0.160 |
Why?
|
| Polyarteritis Nodosa | 1 | 2018 | 66 | 0.160 |
Why?
|
| Ultrasonography, Doppler | 2 | 2019 | 458 | 0.160 |
Why?
|
| Neoplasm Staging | 5 | 2020 | 11007 | 0.160 |
Why?
|
| Endometrium | 2 | 2020 | 424 | 0.150 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2021 | 2737 | 0.150 |
Why?
|
| Kidney Neoplasms | 3 | 2022 | 4245 | 0.150 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2019 | 254 | 0.150 |
Why?
|
| Cysts | 1 | 2022 | 679 | 0.150 |
Why?
|
| Temporal Arteries | 1 | 2018 | 128 | 0.150 |
Why?
|
| Tuberculosis, Urogenital | 1 | 2016 | 9 | 0.150 |
Why?
|
| Ultrasonography | 3 | 2020 | 5982 | 0.140 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2022 | 740 | 0.140 |
Why?
|
| Rectal Fistula | 1 | 2017 | 73 | 0.140 |
Why?
|
| Patients | 1 | 2023 | 900 | 0.140 |
Why?
|
| Algorithms | 1 | 2016 | 13885 | 0.140 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 1107 | 0.140 |
Why?
|
| Peritoneal Neoplasms | 1 | 2022 | 665 | 0.130 |
Why?
|
| Holography | 1 | 2016 | 84 | 0.130 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2016 | 101 | 0.130 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2019 | 265 | 0.130 |
Why?
|
| Counseling | 1 | 2023 | 1523 | 0.130 |
Why?
|
| Radiotherapy, Conformal | 1 | 2018 | 548 | 0.130 |
Why?
|
| Health Literacy | 1 | 2020 | 414 | 0.130 |
Why?
|
| Tissue Adhesives | 1 | 2016 | 179 | 0.130 |
Why?
|
| Testis | 1 | 2018 | 800 | 0.120 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2015 | 86 | 0.120 |
Why?
|
| Tuberous Sclerosis | 1 | 2022 | 1029 | 0.120 |
Why?
|
| Urogenital Neoplasms | 1 | 2015 | 135 | 0.120 |
Why?
|
| Cystic Fibrosis | 2 | 2014 | 1178 | 0.120 |
Why?
|
| Respiratory System Agents | 1 | 2014 | 29 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2019 | 8950 | 0.120 |
Why?
|
| Aminophenols | 1 | 2014 | 78 | 0.120 |
Why?
|
| Pathology | 1 | 2016 | 272 | 0.110 |
Why?
|
| Leiomyosarcoma | 1 | 2017 | 477 | 0.110 |
Why?
|
| Urinary Incontinence | 1 | 2017 | 496 | 0.110 |
Why?
|
| Fibrosis | 1 | 2019 | 2029 | 0.110 |
Why?
|
| Breast Feeding | 1 | 2020 | 1339 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 814 | 0.100 |
Why?
|
| Sternotomy | 1 | 2013 | 121 | 0.100 |
Why?
|
| Physical Therapy Modalities | 1 | 2016 | 550 | 0.100 |
Why?
|
| Staining and Labeling | 1 | 2016 | 1100 | 0.100 |
Why?
|
| Bile Duct Neoplasms | 1 | 2017 | 567 | 0.100 |
Why?
|
| Cholangiocarcinoma | 1 | 2017 | 516 | 0.100 |
Why?
|
| Uterine Neoplasms | 2 | 2020 | 1513 | 0.100 |
Why?
|
| Conscious Sedation | 1 | 2016 | 528 | 0.100 |
Why?
|
| Adenoma | 1 | 2022 | 2174 | 0.100 |
Why?
|
| Acute Disease | 1 | 2022 | 7148 | 0.100 |
Why?
|
| Lymphatic Diseases | 1 | 2013 | 324 | 0.100 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 602 | 0.100 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 725 | 0.090 |
Why?
|
| Women's Health | 1 | 2020 | 2034 | 0.090 |
Why?
|
| Quinolones | 1 | 2014 | 367 | 0.090 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1519 | 0.090 |
Why?
|
| Male | 24 | 2022 | 350027 | 0.090 |
Why?
|
| Drug Monitoring | 1 | 2016 | 956 | 0.090 |
Why?
|
| Retrospective Studies | 12 | 2022 | 77426 | 0.090 |
Why?
|
| Radiation Dosage | 1 | 2018 | 1928 | 0.090 |
Why?
|
| Androgen Antagonists | 1 | 2018 | 1361 | 0.090 |
Why?
|
| Societies, Medical | 4 | 2021 | 3741 | 0.080 |
Why?
|
| Evidence-Based Medicine | 2 | 2019 | 3611 | 0.080 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2011 | 386 | 0.080 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2018 | 2305 | 0.080 |
Why?
|
| Middle Aged | 15 | 2022 | 213367 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 1483 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2214 | 0.080 |
Why?
|
| Prognosis | 3 | 2017 | 29050 | 0.070 |
Why?
|
| Aged | 14 | 2022 | 163253 | 0.070 |
Why?
|
| Lymphoma | 1 | 2016 | 1873 | 0.070 |
Why?
|
| Intestine, Small | 1 | 2013 | 1241 | 0.070 |
Why?
|
| Forecasting | 1 | 2016 | 2949 | 0.070 |
Why?
|
| Radiography, Thoracic | 1 | 2013 | 1265 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2018 | 2019 | 0.070 |
Why?
|
| Thrombosis | 1 | 2020 | 2968 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2016 | 2925 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2016 | 1832 | 0.070 |
Why?
|
| Adult | 14 | 2023 | 214035 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 2862 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2020 | 4440 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 2988 | 0.060 |
Why?
|
| Palliative Care | 1 | 2020 | 3490 | 0.060 |
Why?
|
| Genomics | 1 | 2020 | 5722 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 13096 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 7723 | 0.060 |
Why?
|
| Pregnancy | 4 | 2020 | 29142 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2019 | 63119 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7281 | 0.050 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2019 | 1183 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3132 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 19907 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3239 | 0.050 |
Why?
|
| Consensus | 2 | 2020 | 2958 | 0.050 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2020 | 26 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 15538 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2015 | 3130 | 0.050 |
Why?
|
| Bone Marrow Examination | 1 | 2019 | 157 | 0.040 |
Why?
|
| Menstruation Disturbances | 1 | 2020 | 148 | 0.040 |
Why?
|
| Blood Cell Count | 1 | 2019 | 402 | 0.040 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2018 | 31 | 0.040 |
Why?
|
| Lactation | 1 | 2020 | 412 | 0.040 |
Why?
|
| Standard of Care | 1 | 2022 | 564 | 0.040 |
Why?
|
| Mullerian Ducts | 1 | 2018 | 198 | 0.040 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 53 | 0.040 |
Why?
|
| Laparotomy | 1 | 2020 | 473 | 0.040 |
Why?
|
| Time Factors | 2 | 2016 | 40063 | 0.040 |
Why?
|
| Education | 1 | 2020 | 543 | 0.040 |
Why?
|
| Leukocytosis | 1 | 2018 | 247 | 0.040 |
Why?
|
| Adolescent | 7 | 2020 | 85759 | 0.040 |
Why?
|
| Hematuria | 1 | 2018 | 235 | 0.040 |
Why?
|
| Epididymis | 1 | 2018 | 227 | 0.040 |
Why?
|
| Cholestasis | 1 | 2019 | 378 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 57768 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2017 | 233 | 0.030 |
Why?
|
| United States | 5 | 2021 | 69867 | 0.030 |
Why?
|
| Receptors, Phospholipase A2 | 1 | 2015 | 33 | 0.030 |
Why?
|
| Fallopian Tubes | 1 | 2016 | 182 | 0.030 |
Why?
|
| Flank Pain | 1 | 2015 | 43 | 0.030 |
Why?
|
| Endosonography | 1 | 2019 | 610 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2020 | 764 | 0.030 |
Why?
|
| Nepal | 1 | 2016 | 295 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 39045 | 0.030 |
Why?
|
| Attitude | 1 | 2020 | 774 | 0.030 |
Why?
|
| Leiomyoma | 1 | 2020 | 730 | 0.030 |
Why?
|
| Gelatin | 1 | 2016 | 225 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2016 | 15294 | 0.030 |
Why?
|
| Workplace | 1 | 2020 | 836 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2020 | 1076 | 0.030 |
Why?
|
| Granuloma | 1 | 2016 | 317 | 0.030 |
Why?
|
| Biopsy | 2 | 2016 | 6757 | 0.030 |
Why?
|
| Arthralgia | 1 | 2018 | 456 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2019 | 972 | 0.030 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2020 | 828 | 0.030 |
Why?
|
| Microspheres | 1 | 2016 | 777 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 707 | 0.030 |
Why?
|
| Spleen | 1 | 2019 | 2361 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 2108 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 1640 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2020 | 1548 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1914 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 9230 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2019 | 1062 | 0.030 |
Why?
|
| Proteinuria | 1 | 2015 | 657 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 2085 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2018 | 1462 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2022 | 2848 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2019 | 2513 | 0.030 |
Why?
|
| Regeneration | 1 | 2020 | 1485 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2016 | 1094 | 0.020 |
Why?
|
| Lipids | 1 | 2022 | 3305 | 0.020 |
Why?
|
| Social Support | 1 | 2020 | 2117 | 0.020 |
Why?
|
| Fever | 1 | 2018 | 1614 | 0.020 |
Why?
|
| Animals | 3 | 2018 | 168788 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3474 | 0.020 |
Why?
|
| Sputum | 1 | 2012 | 476 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2020 | 1880 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2020 | 1628 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 2013 | 424 | 0.020 |
Why?
|
| Spirometry | 1 | 2012 | 864 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 72280 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4841 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2019 | 5974 | 0.020 |
Why?
|
| Fertilization in Vitro | 1 | 2016 | 1284 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2013 | 885 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 2726 | 0.020 |
Why?
|
| Developing Countries | 1 | 2020 | 2814 | 0.020 |
Why?
|
| Stem Cells | 1 | 2020 | 3567 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 3778 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 8628 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3509 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 3328 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 56436 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11368 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2020 | 3311 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 3527 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2019 | 7730 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2018 | 13036 | 0.010 |
Why?
|
| Pain | 1 | 2018 | 4987 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 2208 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 21752 | 0.010 |
Why?
|
| Mice | 2 | 2018 | 81178 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 16687 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8387 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11493 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18027 | 0.010 |
Why?
|
| Logistic Models | 1 | 2012 | 13409 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 23337 | 0.010 |
Why?
|
| Prevalence | 1 | 2013 | 15226 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 40559 | 0.010 |
Why?
|
| Child | 1 | 2019 | 77679 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 53280 | 0.010 |
Why?
|